NFE2L2 and chronic myelogenous leukemia, BCR-ABL1 positive: Together with the fact that K-Ras mutations were rare in CML (circa 5% of CML), the findings suggested that this pathway was not responsible for the decreasing Nrf2 transcription by Wogonin.